- Qualifications
- MBChB (MD equivalent) Edinburgh University – winner of Annandale Gold Medal
- Core Training in Psychiatry in Edinburgh
- MPhil course in Psychiatry University of Edinburgh
- Member of Royal College of Psychiatrists UK (MRCPsych )passed 1992
- Higher Training in Edinburgh and Cambridge
- CCST General Adult Psychiatry 1998
- First Substantive Consultant NHS appointment 1998
- S12 and Approved Clinician Status (England) updated to 2022
- S20 AMHP Status (Scotland) achieved in Lothian 2009
- GMC number 3244379. On Specialist Register for Adult Psychiatry with Full Licence to practice
Academic and Research Council Posts
Medical Research Council (UK) Brain Metabolism Unit , Edinburgh 1995-1998Honorary Senior Registrar and MRC Clinical Scientist working under supervision of Professor GM Goodwin
University of Cambridge, Department of Psychiatry. Lecturer in Psychiatry 1996-1998 to Professor ES Paykel
(Brain imaging /genetics/clinical- bipolar disorder and depression)
University of Cambridge, Department of Psychiatry. Honorary Senior Clinical Research Fellow. 1996-2002 – Working to develop and obtain Wellcome Trust Funded Project Grant
Oxford University, Department of Psychiatry, Senior Clinical Research Fellow 2006-2007 – working on Bipolar related projects and to launch the new NGO ‘The Bipolar Foundation” which was a spinout from the University. Successfully moved to external funding after one year
Tenured Consultant Level Posts Previously Held
1998-2002 Cambridge UK
Cambridgeshire and Peterborough Mental Health Partnership NHS Trust University of Cambridge, Department of Psychiatry – Consultant Psychiatrist /Hon Sen. Clin. Res Fellow I held a substantive consultant post providing acute adult services to a large semirural area considerable deprivation on the Cambridgeshire Norfolk borders. I had acute inpatient beds including IPCU beds and several mother and baby beds as well as providing outpatient and community services. Participation in many Tribunals and Managers hearings with required preparation and supervision of preparation of reports. I was contracted to have 4 Academic Sessions in the University which was involved in both Teaching and Research.
I chose to leave this post when I was offered the opportunity of a new post in Oxford.
2002-2006 Oxford UK
Oxfordshire Mental Health Trust and Oxford University Department of Psychiatry: Consultant Psychiatrist (Adult Psychiatry) and Honorary Senior Clinical Research Fellow, June 2002-August 2006 (substantive NHS post). During my initial time in Oxford I had a busy city centre sector catchment area with wide socio-economic spread. It was a very busy acute adult post working within a CMHT. I had responsibility for patients in an acute in-patient unit with occasionally as many as 22-26 in-patients, a large proportion of whom were detained under the Mental Health act. I also had special responsibility for working with all the family practitioners providing healthcare to the majority of students of Oxford University and Oxford Brookes University. In addition I had links to a Family Practice funded specifically to care for with the homeless and recently homeless. At the same time I was involved supervision of Junior Medical Staff, medical student teaching, including formal lecturing in the Oxford University undergraduate curriculum, postgraduate teaching and was also Co- Principal Investigator on Wellcome Trust Research Project Grant.
In Oxford I also had in-patient responsibilities at consultant level fort treatment resistant tertiary patients referred through the Professorial Mood Disorder clinic by Professor Philip Cowen, Professor Guy Goodwin, and Professor John Geddes.
I chose to leave this post when I had the opportunity to move back to work directly with the University Oxford and support to set up a new Mental Health related organisation.
NGO Experience
I was involved as founding director of Equilibrium -the Bipolar Foundation which launched in 2003 as a spin-out from Oxford University Department of Psychiatry. This organisation had a membership network of almost 4000 and contacts from more than 167 countries. Stephen Fry was it’s International Ambassador. It closed in 2015. Between 2007 and 2014 I was working part time with the Bipolar Foundation and undertaking clinical work the rest of the time as a Consultant Psychiatrist.
2014-2016 Scottish Highlands UK
Highland Health Board (Scotland) Consultant Psychiatrist – Argyll and Bute Hospital, Argyll, Scotland, September 2014- December 2016
I moved back to Scotland in 2014 for personal and family reasons. Adult Consultant Psychiatrist with community and in-patient responsibilities for a large rural area of the West Highlands including an island population with pockets of very high deprivation. Cowal and Bute area including the Isle of Bute. An interesting experience of working in a very different community environment. I decided to resign from the post due to remoteness and desire to be based again the South East of England.
Consultant Psychiatrist Based In Oxford Since 2016 with associated Consultancy and Research
Teaching Experience
Clinical and Academic Supervision
I undertook a Clinical Supervisor and Academic Supervisor’s training course with Certification (2012) in the East Anglia/ Eastern Deanery in Norwich and have been involved in supervision trainees at all levels in different capacities at different times.
I have supervised medical students in clinical placements over many years and have been nominated in Oxford University as “Teacher of the Month” on one occasion for medical student teaching. I have taught predominantly students at Oxford, Cambridge and Edinburgh but have also done some supervision and teaching with students from University of East Anglia and University of London.
In terms of formal academic supervision I have supervised and co-supervised students at Masters and PhD level.
I have regularly supervised research and research administration staff.
Teaching and lecturing (selected)
My didactic and tutorial teaching experience is broad having lectured to undergraduates and postgraduates on everything from clinical psychopharmacology to monoamine transporters to medical ethics and end of life issues. I have given regular lectures in the undergraduate and postgraduate programs of the Universities of Edinburgh, Cambridge and Oxford. I have taught both medical students and basic scientists and both clinical and basic scientists. I have had regular experience of teaching GP’s including the Regional GP courses and have given talks to user groups on several occasions. I have also taught on request to groups as disparate as television production companies to patient user groups.
Undergraduate and Postgraduate Lectures and Seminars: (selected)
The Biological basis of Psychopharmacology
Lecture Course, M.Phil in Psychiatry, University of Edinburgh from 1996 (3 Lectures per year)
Neurotransmitter transporters and psychiatric illness- Lecture
University of Edinburgh Medical School, Pharmacology/ Neuroscience Honours – Applied Molecular Biology,January 1996
Biological basis of Affective Disorders
Lecture Course, M.Phil in Psychiatry, University of Edinburgh from 1996
Medical ethics – euthanasia as a paradigm for observing change
University of Edinburgh Medical School, Department of Psychiatry
Regular Lecture, thrice yearly in undergraduate clinical curriculum since 1994-1997
Death Dying and Bereavement
University of Edinburgh Medical School, Department of Psychiatry
Seminar teaching thrice yearly, 1992-1996
Examiner- University of Edinburgh, M.Phil. course in Psychiatry 1995, 1996, Examiner- University of Edinburgh. BSc in Neuroscience 1996 and BSc in Pharmacology 1996
Affective Disorders- an introductory course
2 lectures 3-4 times per year, University of Cambridge – undergraduate clinical syllabus.
University of Cambridge, MRCPsych course 1998
Affective Disorders- Introductory lecture
Course Treatment and Prophylaxis of Affective Disorders- lecture
Treatment of Affective disorders- lecture
Practical Psychopharmacology series of lectures
Seminar teaching in General Psychiatry
University of Cambridge MD. PhD. Program 1998
Involved in organisation of University of Cambridge finals in Medicine and Psychiatry
Lecturer, Undergraduate teaching in Oxford University Medical School
Teaching Experience
Clinical and Academic Supervision
I undertook a Clinical Supervisor and Academic Supervisor’s training course with Certification (2012) in the East Anglia/ Eastern Deanery in Norwich and have been involved in supervision trainees at all levels in different capacities at different times.
I have supervised medical students in clinical placements over many years and have been nominated in Oxford University as “Teacher of the Month” on one occasion for medical student teaching. I have taught predominantly students at Oxford, Cambridge and Edinburgh but have also done some supervision and teaching with students from University of East Anglia and University of London.
In terms of formal academic supervision I have supervised and co-supervised students at Masters and PhD level.
I have regularly supervised research and research administration staff.
Publication Summary from Google Scholar
Cited by
| TITLE | CITED BY | YEAR |
|---|---|---|
| Polymorphism in serotonin transporter gene associated with susceptibility to major depressionAD Ogilvie, S Battersby, G Fink, AJ Harmar, GM Goodwin, VJ Bubb, …The Lancet 347 (9003), 731-733 | 726 | 1996 |
| Heartbeat perception in depressionBD Dunn, T Dalgleish, AD Ogilvie, AD LawrenceBehaviour research and therapy 45 (8), 1921-1930 | 272 | 2007 |
| Improved short-term spatial memory but impaired reversal learning following the dopamine D2 agonist bromocriptine in human volunteersMA Mehta, R Swainson, AD Ogilvie, B Sahakian, TW RobbinsPsychopharmacology 159, 10-20 | 272 | 2001 |
| Abnormal ventral frontal response during performance of an affective go/no go task in patients with maniaR Elliott, A Ogilvie, JS Rubinsztein, G Calderon, RJ Dolan, BJ SahakianBiological psychiatry 55 (12), 1163-1170 | 251 | 2004 |
| Clinical and psychometric correlates of dopamine D2 binding in depressionPJ Shah, AD Ogilvie, GM Goodwin, KP EbmeierPsychological medicine 27 (6), 1247-1256 | 248 | 1997 |
| The burden on informal caregivers of people with bipolar disorderAD Ogilvie, N Morant, GM GoodwinBipolar disorders 7, 25-32 | 224 | 2005 |
| Structure of a variable number tandem repeat of the serotonin transporter gene and association with affective disorderS Battersby, AD Ogilvie, CAD Smith, DHR Blackwood, WJ Muir, JP Quinn, …Psychiatric genetics 6 (4), 177-182 | 166 | 1996 |
| Categorical and dimensional reports of experienced affect to emotion-inducing pictures in depression.BD Dunn, T Dalgleish, AD Lawrence, R Cusack, AD OgilvieJournal of abnormal psychology 113 (4), 654 | 155 | 2004 |
| Altered allelic distributions of the serotonin transporter gene in migraine without aura and migraine with auraAD Ogilvie, MB Russell, P Dhall, S Battersby, V Ulrich, CA Dale Smith, …Cephalalgia 18 (1), 23-26 | 143 | 1998 |
| Presence of multiple functional polyadenylation signals and a single nucleotide polymorphism in the 3′ untranslated region of the human serotonin transporter geneS Battersby, AD Ogilvie, DHR Blackwood, S Shen, MMK Muqit, WJ Muir, …Journal of neurochemistry 72 (4), 1384-1388 | 123 | 1999 |
| The subjective and cognitive effects of acute phenylalanine and tyrosine depletion in patients recovered from depressionJP Roiser, A McLean, AD Ogilvie, AD Blackwell, DJ Bamber, I Goodyer, …Neuropsychopharmacology 30 (4), 775-785 | 113 | 2005 |
| Neuropsychological processing associated with recovery from depression after stereotactic subcaudate tractotomyT Dalgleish, J Yiend, J Bramham, JD Teasdale, AD Ogilvie, G Malhi, …American Journal of Psychiatry 161 (10), 1913-1916 | 65 | 2004 |
| Association of short alleles of a VNTR of the serotonin transporter gene with anxiety symptoms in patients presenting after deliberate self harmJ Evans, S Battersby, AD Ogilvie, CAD Smith, AJ Harmar, DJ Nutt, …Neuropharmacology 36 (4-5), 439-443 | 64 | 1997 |
| Assisted suicide for depression: the slippery slope in action?AD Ogilvie, SG PottsBMJ 309 (6953), 492-493 | 60 | 1994 |
| The accuracy of self-monitoring and its relationship to self-focused attention in dysphoria and clinical depression.BD Dunn, T Dalgleish, AD Lawrence, AD OgilvieJournal of Abnormal Psychology 116 (1), 1 | 58 | 2007 |
| Allelic variation in the serotonin 5-HT2C receptor gene and migrainePWJ Burnet, PJ Harrison, GM Goodwin, S Battersby, AD Ogilvie, J Olesen, …Neuroreport 8 (12), 2651-2563 | 57 | 1997 |
| Hair loss during fluoxetine treatmentAD OgilvieThe Lancet 342 (8884), 1423 | 49 | 1993 |
| Interaction between the BDNF gene Val/66/Met polymorphism and morning cortisol levels as a predictor of depression in adult womenJ Herbert, M Ban, GW Brown, TO Harris, A Ogilvie, R Uher, TKJ CraigThe British Journal of Psychiatry 201 (4), 313-319 | 38 | 2012 |
| Association between the serotonin transporter gene and affective disorder: the evidence so farAD Ogilvie, AJ HarmarMolecular Medicine 3, 90-93 | 37 | 1997 |
| Efficacy, safety and tolerability of duloxetine 60 mg once daily in major depressionPJ Cowen, AD Ogilvie, J GamaCurrent medical research and opinion 21 (3), 345 | 34 | 2005 |
| Clozapine and hyponatraemiaAD Ogilvie, MF CroyThe Lancet 340 (8820), 672 | 34 | 1992 |
| In situ hybridisation.AD Ogilvie, NC Wood, E Dickens, D Wojtacha, GW DuffAnnals of the rheumatic diseases 49, 434-439 | 29 | 1990 |
| The serotonin transporter gene and affective disorderAJ Harmar, AD Ogilvie, S Battersby, CAD Smith, DHR Blackwood, …Cold Spring Harbor symposia on quantitative biology 61, 791-795 | 12 | 1996 |
| Screening for disorders of serotonergic dysfunctionS Battersby, G Fink, GM Goodwin, AJ Harmar, AD Ogilvie, CAD SmithUS Patent 6,165,716 | 8 | 2000 |
| The effects of acute tyrosine and phenylalanine depletion in recovered depressionJ Roiser, A McLean, A Ogilvie, A Balckwell, B SahakianSAGE PUBLICATIONS LTD 18 (3), A16-A16 | 2 | 2004 |
| Equilibrium-The bipolar foundation, and the international bipolar disorder survey. Who are we are and what are we doing?A Ogilvie, A Barrera, J Geddes, G GoodwinJournal of Affective Disorders 107 | 2008 | |
| International aspects of bipolar disorder results from a major international survey of more than 2600 peopleA Ogilvie, A Barrera, J Geddes, G Goodwin | 2008 | |
| Managing the aftermath of mania-Newcastle, 2 September 2005: Consensus Meeting StatementAH Young, J Cookson, B Elliott, JSE Hellewell, RH McAllister-Williams, …Journal of Psychopharmacology 20 (2_suppl), 51-54 | 2006 | |
| 5-HT transporter gene polymorphism and depressionAD Ogilvie, S Battersby, CAD Smith, DHR Blackwood, WJ Muir, …British Journal of Pharmacology 122, U160-U160 | 1997 | |
| Haplotype analysis of the serotonin transporter gene in mood disorder.S Battersby, AD Ogilvie, CAD Smith, DHR Blackwood, WJ Muir, …American Journal of Medical Genetics 74 (6), 619-619 | 1997 | |
| Function and dysfunction in the nervous systemAJ Harmar, AD OgilvieTrends in Neurosciences 19 (11), 449-450 | 1996 | |
| Subacute myopathy during omeprazole therapyAD OGILVIE, MF CROYLancet (British edition) 340 (8820) | 1992 | |
| gene Val/66/Met polymorphism and BDNF Interaction between theJ Herbert, M Ban, GW Brown, TO Harris, A Ogilvie, R Uher, TKJ Craig | ||
| Categorical and dimensional reports of experienced affect to emotion-inducingBD Dunn, T Dalgleish, AD Lawrence, R Cusack, A Ogilvie |
Articles 1–34
Dr Alan Ogilvie 